Test Price
2,800 AEDโ Home Collection Available
VHL Gene (von Hippel-Lindau Syndrome) Genetic Test in UAE | 2,800 AED | DHA Licensed
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation by DHA-licensed clinicians.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The VHL gene analysis identifies germline mutations associated with von Hippel-Lindau syndrome, a hereditary cancer predisposition disorder. This next-generation sequencing (NGS) test provides comprehensive coverage of the entire VHL gene, enabling early detection and guiding surveillance for associated tumors such as renal cell carcinoma and pheochromocytoma. The assay utilizes Illumina NovaSeq technology to deliver high-confidence variant calls across all coding exons and flanking intronic regions.
| Feature | Our Test (VHL NGS) | Closest Alternative (Sanger) |
|---|---|---|
| Precision | 99.9% Sensitivity, Full Gene Coverage | Targeted Hotspot Analysis, Misses Novel Mutations |
| Methodology | Next-Generation Sequencing (Illumina NovaSeq) | Capillary Electrophoresis Sanger |
| Turnaround Time | 3โ4 Weeks | 6โ8 Weeks |
Physician Insight & Safety Protocols
โGenetic testing for VHL mutations offers valuable risk stratification; however, results must be correlated with clinical findings by a qualified specialist. This test aids in early detection but does not replace comprehensive clinical evaluation. A multidisciplinary approach remains fundamental for optimal management of von Hippel-Lindau syndrome.โ
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
โ ๏ธ Important Medication Notice
Do not discontinue any prescribed medications without consulting your physician. Abrupt changes could lead to adverse health outcomes.
Exclusion Criteria & Emergency Red Flags
Exclusion Guidelines
- This test is intended for individuals with a personal or family history suggestive of von Hippel-Lindau syndrome, not for general population screening.
- Pregnant individuals or those who have had a recent blood transfusion should inform the phlebotomist before sample collection.
- Emergency Red Flags: Sudden neurological deficits, acute vision changes, severe hypertension, or signs of internal bleeding require immediate emergency evaluation, not just genetic testing.
Patient FAQ & Clinical Guidance
1. What does the VHL Genetic Test detect?
This test detects germline mutations in the VHL gene, confirming von Hippel-Lindau syndrome and guiding cancer surveillance. It analyzes the complete coding region using next-generation sequencing, offering near 100% sensitivity and specificity. Results help identify at-risk family members and tailor preventive strategies for renal, adrenal, and central nervous system tumors.
2. How should I prepare for the blood sample collection?
No fasting is required; inform your phlebotomist of any medications or recent transfusions, and maintain usual hydration. Our VIP mobile team will visit your home or office at the scheduled time within the 8 AM to 11 PM window. Ensure you have your Emirates ID and insurance card ready for verification.
3. What is the turnaround time for results, and how will I receive them?
Results are delivered within 3โ4 weeks via secure email and explained in a post-test teleconsultation with a DHA-licensed genetic counselor. A comprehensive report includes variant interpretation according to ACMG guidelines and recommendations for clinical follow-up. You will also receive a copy for your referring physician.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates in full compliance with UAE federal data protection and healthcare laws. Your personal and genetic data are handled under the provisions of Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. All test results are encrypted and securely stored with access restricted to authorized medical personnel only.
Clinical & Logistical Metadata
| Test Name | VHL Gene (von Hippel-Lindau Syndrome) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3โ4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood |
| Methodology Used | Next-Generation Sequencing (Illumina NovaSeq) |
| ICD-10-CM Code | Q85.8 |
| LOINC Code | 21636-6 |
| DHA Facility License & Laboratory Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians